Prostate Cancer – Forum, February 19, 2021

150 150 MaLMIC - Machine Learning in Medical Imaging Consortium

Join the Machine Learning in Medical Imaging Consortium (MaLMIC) for an opportunity to network on machine learning

Monthly Virtual Forum Series on Zoom

Friday, February 19, 2021
3:30 to 5:30 p.m. EST

Dr. Haider, a radiologist, discussed the prostate cancer unmet clinical need followed by two researchers, Dr. Mousavi and Mr. Orlando, describing their machine learning research work in the area. This was followed by discussion focused on opportunities to collaborate and share resources.

Monthly Virtual Forum Series on Zoom

Friday, February 19, 2021
3:30 to 5:30 p.m. EST

Dr. Haider, a radiologist, discussed the prostate cancer unmet clinical need followed by two researchers, Dr. Mousavi and Mr. Orlando, describing their machine learning research work in the area. This was followed by discussion focused on opportunities to collaborate and share resources.

Masoon Haider

MRI in Prostate Cancer: Opportunities for AI

Masoom Haider, MD, FRCPC
Radiologist and Clinician Scientist, Joint Department of Medical Imaging, University of Toronto

MRI has established itself as an adjunctive test in detecting occult prostate cancer. New guidelines will recommend MRI for patients with elevated PSA and no prior biopsy resulting in a marked increase in MRI in the province. There are several use cases that can benefit from the application of machine learning to improve diagnostic performance and outcomes, which was reviewed.

Parvin Mousavi

Computer-assisted diagnosis and prognosis of prostate cancer diagnosis: AI, advances, and democratization of access to innovation

Parvin Mousavi, PhD
Professor, School of Computing, Queen’s University

As the role of ultrasound in accurate guidance and detection of prostate cancer evolves, so do innovations in deep learning and machine learning approaches. Meanwhile, the clinical translation of such innovations is hindered by the noisy and heterogenous nature of imaging signals and gold-standard pathology. The talk reviewed our recent progress in this area.